BIOL242 Hw #2 20 points Name A patient in your care undergoes kidney dialysis tr
ID: 3516840 • Letter: B
Question
BIOL242 Hw #2 20 points Name A patient in your care undergoes kidney dialysis treatments for kidney failure. Explain to the patient why they are prescribed erythropoietin (EPO). 1 pt 1. 2. Where in the body, which cell types, do you expect to have EPO receptors? 2 pts 3. Joe Schmoe has a blood volume of 5 L. 58% of his blood is composed of RBCs?1% ofhis blood is composed of WBCs and platelets. Approximately how many liters of water does his blood contain? 1 pt A. 41 L B. 4.1L C. 2L D. 1.5 L E. I L 4. What is Joe's hematocrit? 1 pt A patient's blood work shows elevated insulin levels. Does this patient likely have Type 1 or Type 2 diabetes? Defend your answer. 2 pts 5. 6. In the above patient, you call for an HbA1C test. What is HbA1C? What does this test specifially how? 2 pts 7. A couple expecting their second child is worried about Rh incompatibility. Their first child was Rh+ They have their blood typed. Which result would be both a possibility AND cause for alarm2 1pts A. both parents Rh B. both parents Rh+ C man Rh- and woman Rh+ D. man Rh + and woman Rh-Explanation / Answer
Question 1
Answer
The most common complication of the kidney failure is anemia. This is due to insufficient production of erythropoietin from the kidneys. Erythropoietin is essential for the production of RBC. so the administration of Erythropoietin to the patient dialysis improves patient condition.
Question 2
Answer
Erythropoietin receptors come from cytokine receptors. these receptors are present in Erythroid progenitors, megakaryocytes, myeloid cells, and endothelial progenitors.
Question 3
The answer is 2 L
The blood cells occupy 60% of total blood volume (5 L). the remaining volume is 2L.
Question 4
Answer
The hematocrit value is equal to the % volume of RBC in blood. The hematocrit value is 58%
Related Questions
Navigate
Integrity-first tutoring: explanations and feedback only — we do not complete graded work. Learn more.